Stage | Treatment | Number of patients | 5-Year relapse rate (%) | Second relapse, n | 5-Year disease-specific survival (%) | 5-Year overall survival (%) | Dead of disease/treatment, n (%) | Death other cause, n (%) |
---|---|---|---|---|---|---|---|---|
 | Surv | 313 | 19.3 | 3a (1%) | 100 | 99 | 0 | 2 (1) |
I | RT | 159 | 2 | 0 | 100 | 99.3 | 0 | 1 (1) |
 | Carb | 73 | 2 | 0 | 100 | 100 | 0 | 0 |
 | RT | 19 | 8.3 | 0 | 100 | 92.3 | 0 | 1 (3) |
II | CHT | 65 | 4.5 | 0 | 100 | 90.7 | 3 (5%) | 2 (3) |
 | Other | 3 | 0 | 0 | 100 | 100 | 0 | 0 |
III | CHT | 17 | 0 | 0 | 100 | 100 | 0 | 0 |